The basic principle in the Biocidal Products Regulation ((EU) No 528/2012 (BPR)) is that a biocidal product (BP) must be authorised before it can be made available on the market or used in the European Union (EU)/ European Economic Area (EEA).
This takes place in two consecutive steps. As the first step, the active substance is evaluated and, provided the criteria are fulfilled, is then approved in a specified product-type (PT). The second step is the authorisation of each BP consisting of, containing or generating the approved active substance(s).
This document concerns the first step, approval of active substances.
October 2016
Collegati
EPA US
ALOHA® is the hazard modeling program for the CAMEO® software suite, which is used widely to plan for and respond to chemical eme...
ID 18802 | 26.01.2023 / In allegato
Il tetracloroetilene è un alogenuro organico, usato principalmente come solvente nelle lav...
Decreto 15 Febbraio
Entrata in vigore dei testi, nelle lingue inglese e francese, pubblicati nel Supplemento 9.5 della Farmacopea europea ...
Testata editoriale iscritta al n. 22/2024 del registro periodici della cancelleria del Tribunale di Perugia in data 19.11.2024
